PROCTER & GAMBLE HEALTH L (PGHL)

NSE: ₹6,201.00
BSE: ₹6,200.10
Stock Performance
Corporate Announcements
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet – Intimation

We wish to inform you that the management of the Company will be hosting a virtual connect with analysts/ institutional investors on June 18th at 2.30 pm IST. Institutional investors/Analysts interested in joining the connect are requested to complete the registration on link provided in the attached intimation by June 8, 2026. The company will share meeting link and details to the participants who have registered, separately.

2026-06-04 14:25:42
Compliances-Reg.24(A)-Annual Secretarial Compliance

Please find attached signed Annual Secretarial Compliance report for the year ended March 31, 2026

2026-05-27 15:00:02
Record Date For Purpose Of Dividend

Record date for purpose of dividend

2026-05-26 17:46:40
Corporate Action-Board approves Dividend

Board has recommended final dividend for the Financial Year 2025-26, subject to approval of shareholders.

2026-05-26 17:33:14
Announcement under Regulation 30 (LODR)-Press Release / Media Release

Please find attached press release for the quarter and financial year ended March 31, 2026.

2026-05-26 17:29:53
Announcement under Regulation 30 (LODR)-Change in Management

Dear Sir, Please find attached intimation for re appointment of Independent Director.

2026-05-26 17:27:53
Outcome Of The Board Meeting Held On May 26, 2026

Dear Sir, Please find attached audited financial results for the year ended March 31, 2026.

2026-05-26 17:03:27
Board Meeting Outcome for Outcome Of The Board Meeting Held On May 26, 2026

We are enclosing herewith the following: a. Audited Financial Results for the Financial Year ended March 31, 2026, as per format prescribed under Regulation 33 of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015; b. Auditor’s Report, in respect of the aforementioned Financial Results, as furnished by the Statutory Auditors of the Company; c. A declaration with respect to Audit Report with unmodified opinion to the aforementioned Audited Financial Results We are pleased to further inform you that the Board of Directors of the Company at its meeting held today, inter alia, have recommended a dividend of Rs. 45 per Equity Share (Nominal Value of Rs. 10/- each), for the Financial Year ended March 31, 2026. The divided shall be paid on or before September 25, 2026, on approval of the Members at the ensuing Annual General Meeting.

2026-05-26 16:54:48
Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 – Sale Of Immovable Properties

Dear Sir, Please find attached our intimation under Regulation 30 of the SEBI (LODR) Regulations, 2015. Request you to kindly take the same on record.

2026-04-30 22:49:38
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyProcter & Gamble Health Ltd 2CIN NO.L99999MH1967PLC013726 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00 4Highest Credit Rating during the previous FY NIL 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: ZEAL RUPANI Designation: Company Secretary EmailId: SHAH.ZS@PG.COM Name of the Chief Financial Officer: SHASHANK SROWTHY Designation: CFO Director EmailId: srowthy.sr@pg.com Date: 06/04/2026 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.

2026-04-06 17:02:38

Quarterly Financials

Consolidated Standalone
Particulars Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Revenue from Operations 301.18 304.93 309.97 252.48 283.88 313.41 309.77 310.99 338.74 324.92 373.86 370.45
YOY Revenue Growth % 1.79% 2.48% 0% -21.33% -5.74% 2.78% -0.06% 23.17% 19.33% 3.67% 20.69% 19.12%
Other Income 5.46 6.05 5.18 2.27 2.13 3.28 3.96 3.11 4.03 4.95 4.36 4.00
Total Income 306.64 310.98 315.15 254.75 286.01 316.69 313.73 314.10 342.77 329.87 378.22 374.45
Total Expenses + 262.51 222.93 215.43 192.03 242.99 205.29 192.04 235.57 253.96 210.85 269.40 241.24
Cost of Materials Consumed 74.31 87.31 70.84 64.66 67.42 48.17 61.60 90.82 59.54 78.13 84.47 85.19
Employee Benefit Expense 55.40 60.64 57.43 48.46 48.63 46.22 47.05 48.79 56.01 53.88 61.81 50.86
Other Expenses 106.69 68.49 60.50 62.72 107.83 65.10 63.56 82.56 98.40 82.37 91.77 91.13
Operating Profit 38.67 82.00 94.54 60.45 40.89 108.12 117.73 75.42 84.78 114.07 104.46 129.21
OPM % 12.8% 26.9% 30.5% 23.9% 14.4% 34.5% 38% 24.3% 25% 35.1% 27.9% 34.9%
Profit Before Tax + 44.13 88.05 99.72 62.72 22.83 111.40 121.69 78.53 88.81 119.02 108.82 133.21
Tax Expense 14.31 22.48 27.65 16.16 6.05 29.07 30.79 17.35 22.63 30.48 31.23 38.61
Tax % 32.4% 25.5% 27.7% 25.8% 26.5% 26.1% 25.3% 22.1% 25.5% 25.6% 28.7% 29%
Profit After Tax 29.82 65.57 72.07 46.56 16.78 82.33 90.90 61.18 66.18 88.54 77.59 94.60
EPS (Basic) 17.96 39.50 43.40 28.00 10.11 49.60 54.76 36.86 39.87 53.34 46.74 56.99

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022
Revenue from Operations 1,407.97 934.17 867.38 928.44 1,114.41
YOY Revenue Growth % 50.72% 7.7% -6.58% -16.69% -
Other Income 17.34 10.35 13.50 12.93 13.19
Total Income 1,425.31 944.52 880.88 941.37 1,127.60
Total Expenses + 975.45 632.90 630.39 671.30 829.92
Cost of Materials Consumed 307.33 200.59 222.81 244.92 323.72
Employee Benefit Expense 222.56 142.06 166.53 150.77 167.56
Other Expenses 363.67 211.22 191.71 230.97 338.64
Operating Profit 432.52 301.27 236.99 257.14 284.49
OPM % 30.7% 32.3% 27.3% 27.7% 25.5%
Profit Before Exceptional 449.86 311.62 250.49 270.07 253.37
Exceptional Items 0.00 0.00 0.00 0.00 0.00
Profit Before Tax + 449.86 311.62 250.49 270.07 253.37
Tax Expense 122.95 77.21 66.29 70.42 60.85
Tax % 27.3% 24.8% 26.5% 26.1% 24%
Profit After Tax 326.91 234.41 184.20 199.65 192.52
EPS (Basic) 196.94 141.22 111.00 120.30 116.00

Balance Sheet

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022
ASSETS
Non-Current Assets + 285.09 267.81 0.00 0.00 196.22
Property, Plant & Equipment 99.24 104.63 0.00 0.00 106.35
Capital Work in Progress 13.59 10.96 0.00 0.00 40.60
Non-Current Investments 0.00 0.00 0.00 0.00 0.00
Goodwill 0.00 0.00 0.00 0.00 0.00
Other Intangible Assets 0.47 7.11 0.00 0.00 2.71
Current Assets + 556.26 526.39 0.00 0.00 697.50
Inventories 136.65 109.37 0.00 0.00 115.21
Trade Receivables 164.26 145.40 0.00 0.00 83.44
Cash and Cash Equivalents 177.24 182.08 0.00 0.00 319.40
Current Investments 0.00 0.00 0.00 0.00 0.00
LIABILITIES & EQUITY
Total Equity 524.55 536.96 0.00 0.00 0.00
Equity Share Capital 16.60 16.60 0.00 0.00 16.60
Other Equity 507.95 520.36 0.00 0.00 599.89
Non-Current Liabilities 61.87 41.93 0.00 0.00 41.40
Current Liabilities 254.93 215.31 0.00 0.00 235.83
Total Liabilities 316.80 257.24 0.00 0.00 277.23

Cash Flow Statement

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022
Cash from Operating Activities 337.79 168.69 0.00 0.00 169.52
Cash from Investing Activities 1.26 9.59 0.00 0.00 -25.54
Cash from Financing Activities -343.92 -234.74 0.00 0.00 -288.63
Net Increase/Decrease in Cash -4.87 -56.46 0.00 0.00 -144.65